Literature DB >> 8813986

Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism.

S Stöckler1, F Hanefeld, J Frahm.   

Abstract

BACKGROUND: The creatine/creatine-phosphate system is essential for the storage and transmission of phosphate-bound energy in muscle and brain. In infants, inefficiency or failure of this metabolic pathway can impair the development of motor control and mentation.
METHODS: We studied and treated an infant with extrapyramidal signs who was shown--by assay for urinary creatinine and by analysis of brain metabolites with use of nuclear magnetic resonance spectra--to have depletion of body and brain creatine, due to inborn deficiency of guanidinoacetate methyltransferase (GAMT).
FINDINGS: Long-term oral administration of creatine-monohydrate (4-8 g per day) to this index patient resulted in substantial clinical improvement, disappearance of magnetic resonance (MRI) signal abnormalities in the globus pallidus, and normalisation of slow background activity on the electroencephalogram (EEG). During the 25-month treatment period, both brain and total body creatine concentrations became normal.
INTERPRETATION: Oral creatine replacement has proved to be effective in one child with an inborn error of GAMT. It may well be effective in the treatment of other disorders of creatine synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813986     DOI: 10.1016/s0140-6736(96)04116-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

1.  Increase of cerebral phosphocreatine in normal rats after intracerebroventricular administration of creatine.

Authors:  R Rebaudo; R Melani; F Carità; L Rosi; V Picchio; P Ruggeri; N Izvarina; M Balestrino
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

2.  X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28.

Authors:  Kimberly A Hahn; Gajja S Salomons; Darci Tackels-Horne; Tim C Wood; Harold A Taylor; Richard J Schroer; Herbert A Lubs; Cornelis Jakobs; Rick L Olson; Kenton R Holden; Roger E Stevenson; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

Review 3.  Adverse effects of creatine supplementation: fact or fiction?

Authors:  J R Poortmans; M Francaux
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 4.  Imaging of neurogenetic and neurometabolic disorders of childhood.

Authors:  Andrea Gropman
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

5.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.

Authors:  G S Salomons; S J van Dooren; N M Verhoeven; K M Cecil; W S Ball; T J Degrauw; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

6.  Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials.

Authors:  Konstantinos I Avgerinos; Nikolaos Spyrou; Konstantinos I Bougioukas; Dimitrios Kapogiannis
Journal:  Exp Gerontol       Date:  2018-04-25       Impact factor: 4.032

7.  Carrier frequency of guanidinoacetate methyltransferase deficiency in the general population by functional characterization of missense variants in the GAMT gene.

Authors:  Caro-Lyne Desroches; Jaina Patel; Peixiang Wang; Berge Minassian; Christian R Marshall; Gajja S Salomons; Saadet Mercimek-Mahmutoglu
Journal:  Mol Genet Genomics       Date:  2015-05-24       Impact factor: 3.291

8.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

9.  Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.

Authors:  Dae Won Kim; Seong-Il Yeo; Hea Jin Ryu; Ji-Eun Kim; Hong-Ki Song; Oh-Shin Kwon; Soo Young Choi; Tae-Cheon Kang
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

Review 10.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.